Latest Undisclosed Funding Rounds
Funding announcements whose series or stage was not named. Round amounts and investor roles are shown where disclosed.
- Rounds
- 2,305 All time
- Disclosed funding
- $375.2B 1239 disclosed amounts
- Median round
- $8.9M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
APEXX GlobalCompany profile APEXX Global connects payment providers through one orchestration platform for enterprise merchants. APEXX Global connects payment providers through one orchestration platform for enterprise merchants. | ≤$10M | StrategicUndisclosed | Fintech | United Kingdom | Investors | |
| PM Pix MídiaCompany profile Pix Mídia provides internal communications software spanning workplace screens, mobile apps, web and intranet. Pix Mídia provides internal communications software spanning workplace screens, mobile apps, web and intranet. | R$2.9M | Equity investmentUndisclosed | Enterprise software | Brazil | Investors | |
| Q QuipuCompany profile Quipu provides alternative credit scoring and lending tools for microbusinesses in Latin America. Quipu provides alternative credit scoring and lending tools for microbusinesses in Latin America. | $1.1M | Pre-Series A bridgeUndisclosed | Fintech | Colombia | Investors | |
Evergreen SelectCompany profile Produces cultivated beef for integration into existing food-production systems. Produces cultivated beef for integration into existing food-production systems. | $6M | Undisclosed | Foodtech | United States | Investors | |
| B BCASCompany profile Provides flexible student financing solutions through income share agreements and installment plans Provides flexible student financing solutions through income share agreements and installment plans | €30M | DebtUndisclosed | Edtech | Spain | Investors | |
| B BEESYCompany profile Provides AI-enabled behavioral-science market research and insights for biopharmaceutical companies Provides AI-enabled behavioral-science market research and insights for biopharmaceutical companies | Undisclosed | StrategicUndisclosed | Healthtech | United States | Investors | |
| MM Mersal Media CapitalCompany profile Mersal Media Capital develops and invests in digital media assets in the Middle East. Mersal Media Capital develops and invests in digital media assets in the Middle East. | SAR 5M | Undisclosed | Media & gaming | Saudi Arabia | Investors Undisclosed | |
| IB Imbed BiosciencesCompany profile Develops advanced synthetic antimicrobial and tissue regeneration solutions for wound care Develops advanced synthetic antimicrobial and tissue regeneration solutions for wound care | Undisclosed | StrategicUndisclosed | Healthtech | United States | Investors | |
| T TissiumCompany profile Develops biomorphic programmable polymers that repair nerves and tissue without stitches Develops biomorphic programmable polymers that repair nerves and tissue without stitches | ≤€30M | EIB financing facilityUndisclosed | Healthtech | France | Investors | |
| IM Develops AI-driven drug discovery and oncology treatments | $5M | StrategicUndisclosed | Biotech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1Innovate UK
Emerald, Go Eve, Nearhuman
39rounds0led - 2NVIDIA
Noeri, Applied Compute, Riverlane
32rounds1led - 3Bethnal Green Ventures
Excelas, HeyLina, Amytis
25rounds0led - 4Future of Health Grant
Healium, NeuroTreasure Solutions, Entrelacs
20rounds0led - 5Peak XV Partners
PowerUp Money, Hex, Meragi
19rounds3led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.